|
|
|
市場調查報告書
醫藥品製造，研究，包裝的受託:全球市場
Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
| 出版商 |
BCC Research |
| 出版日期 |
2011年09月 |
商品編碼 |
210211 |
| 內容資訊 |
英文 322 Pages |
| 價格 |
|
|
醫藥品製造，研究，包裝的受託:全球市場 是由出版商BCC Research在2011年09月所出版的。
這份英文市場調查報告書包含322 Pages 價格從美金4850起跳。
全球醫藥品製造·研究開發受託機關的收益2010年達到1,965億美元，2011年為2,179億美元，預計到2016年為止將達到3,606億美元。
本報告提供全球醫藥品製造·研究開發·包裝受託市場相關調查分析，外包的歷史，服務概要，法律規範趨勢，北美，歐洲，新興市場等各不同地區趨勢，參與企業簡介等彙整資料，為您概述為以下內容。
第1章 簡介
第2章 摘要
第3章 概要
第4章 受託製造概要
- 受託製造業者的種類
- 受託製造途徑
- 受託製造的優點與缺點
- 受託製造業者
- 其他的事實
第5章 研究開發受託概要
- 研究開發受託機關的服務
- 研究開發受託機關
- 研究開發受託機關的研究
第6章 包裝受託概要
- 包裝受託業者的必要性
- 包裝受託業者
- 包裝受託的僱用
- 包裝的種類
第7章 企劃經營管理
- 企劃經營管理的方法
- 企劃經營管理的流程
- 專案經理所扮演的角色
- 技術轉讓
第8章 相關法規方面
第9章 北美產業結構
第10章 歐洲產業結構
第11章 新興市場的產業結構
第12章 技術轉讓
- 技術轉讓的理由
- 技術轉讓中的問題
- 技術轉讓契約的種類
- 成功企劃的特徵
第13章 新開發
第14章 北美市場分析
第15章 歐洲市場分析
第16章 其他各國·新興市場分析
第17章 各地區市場佔有率
第18章 北美市場應用
- 心血管藥物
- 生殖相關藥物
- 癌症藥物
- 止痛藥
- 抗病毒藥物
- 抗生素
- 其他
第19章 歐洲市場應用
第20章 其他各國的應用
第21章 專利分析
第22章 目前環境
第23章 企業簡介
第24章 附錄
圖表
Abstract
REPORT HIGHLIGHTS
THIS REPORT CONTAINS
- An overview of the current and future characteristics of the global market
for contract manufacturing, research, and packaging in the pharmaceuticals
industry
- Analysis of global market trends, with data from 2010, estimates for 2011,
and projections of compound annual growth rates (CAGRs) through 2016
- Exploration of the needs, services offered, criteria for selection, and
the advantages of outsourcing
- Discussion of regulatory requirements
- A breakdown of revenues by bulk as well as by dosage forms of solid,
liquid, and semisolid pharmaceuticals
- Examination of over-the-counter (OTC), nutritional, and drug-delivery
products
- Comprehensive company profiles.
SUMMARY FIGURE
GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE,
2009-2016 ($ BILLIONS)
Source: BCC Research
STUDY OBJECTIVE
The objective of BCC Research in conducting this study is to provide an
overview of the current situation and future capabilities of the global
pharmaceutical contract manufacturing, research, and packaging markets. The
study provides a global as well as a regionally specific market overview. The
report emphasizes the current and future outlook of the pharmaceutical
contract manufacturing market, with a comprehensive analysis of the overall
pharmaceutical and biotechnology outsourcing industry.
The current report discusses and outlines the current capabilities as well as
the needs of the pharmaceutical contract manufacturing, research, and
packaging markets. In addition, it discusses company and market strategies to
further enhance the market. The report includes the different types of
contract manufacturing and, more specifically, the services offered by global
contract manufacturers, researchers, and packagers. The report also discusses
the methods best used to identify an effective contract manufacturer as well
as the advantages of contract manufacturing and outsourcing. The report
highlights the need for project management, provides market forecasts for
different aspects of contract manufacturing specific to each region, and
examines the role of market leaders in the industry. Regulatory requirements
and new developments in the market are also discussed in the report.
The report encompasses the revenues gained from contract manufacturing in each
specific market and in each specific region. Sales analysis was performed on
specific categories of drugs and dosage forms including API/bulk drugs and
solid, liquid, and semisolid dosage forms. Sales analyses were also performed
on revenues gained from contract packaging and contract research. The sales
figures discussed are for the examined period of 2009 to 2011. Sales figures
were also forecast for the following 5-year period from 2011 through 2016.
Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products
are discussed in a separate section of this report.
REASONS FOR DOING THIS STUDY
The majority of pharmaceutical companies are now using contract manufacturing,
research, and packaging services. To save costs and product development time
while simultaneously being effective, efficient, and productive,
pharmaceutical companies are relying on contract manufacturers to fulfill many
basic as well as specialized competencies. This study discusses the different
types of contracting companies, their roles, and the share of the market they
claim. New developments and new technologies warrant the issuing of this
report, which is an important resource for anyone analyzing the discussed
markets.
Trends in outsourcing and new emerging markets for outsourcing are providing a
new look to the market and greater options to pharmaceutical companies. The
industry is seeing an increase in outsourcing as contract manufacturers,
researchers, and packagers provide cheaper options as well as region-specific
suppliers. The new state-of-the-art packaging facilities as well as expensive
research facilities and capabilities of research organizations are enhancing
the overall growth of the contract manufacturing industry. Contract
manufacturers are providing pharmaceutical companies with expertise in all
forms that the companies do not have available in-house.
SCOPE OF THE STUDY
The scope of this study encompasses the contract manufacturing, research, and
packaging markets. BCC analyzes each market and its applications for contract
manufacturing by its need for outsourcing, regulatory environment, technology
involved, market projections, and market share. Technological issues include
the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this
study. BCC conducted a comprehensive literature search, which included
technical newsletters and journals, and many other sources. Data were
collected through interviews and correspondence with various analytical,
chemical, pharmaceutical, and contracting experts. Market sizing estimates
and projections were based on estimates such as the current number of end
users, potential end users, mergers and acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this
study. Included were manufacturers and end users of pharmaceuticals through
contract manufacturing and research. Data were gathered from various industry
sources. BCC spoke with officials and physicians within the industry, and
consulted newsletters, company literature, product literature, and a host of
technical articles, journals, indexes, and abstracts. Exhaustive
investigations of databases by key terminology were completed. In addition,
data were compiled from current financial, trade, and government sources.
ABOUT THE AUTHOR
The study has been carried out by a team of professionals in the biotechnology
industry. The project manager for this project is Shalini S. Dewan, who holds
a master' s degree in pharmaceutical chemistry and has over 14 years of
industry experience. Among the research topics she has covered are studies on
compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl
acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India
for her work and has worked with top companies in India and in the U.S.
The lead consultant for this project was Ms. Taruna Chhabra, who holds a
bachelor' s degree in biology and is a member of the National Honor Society for
Biological Sciences.
Table of Contents
Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
Chapter - 1: INTRODUCTION - Complimentary
- STUDY OBJECTIVE
- REASONS FOR DOING THIS STUDY
- INTENDED AUDIENCE
- SCOPE OF THE STUDY
- METHODOLOGY
- INFORMATION SOURCES
- ABOUT THE AUTHOR
- RELATED BCC RESEARCH REPORTS
- BCC ONLINE SERVICES
- DISCLAIMER
Chapter - 2: SUMMARY
- Table 0 : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT
RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016
- Figure 0 : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT
RESEARCH ORGANIZATIONS REVENUE, 2009-2016
Chapter - 3: OVERVIEW
- DEFINITIONS
- HISTORY OF OUTSOURCING
- Table 1 : KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
Chapter - 4: OVERVIEW OF CONTRACT MANUFACTURING
- TYPES OF CONTRACT MANUFACTURERS
- CONTRACT MANUFACTURING TRAITS
- ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
- SELECTING A CONTRACT MANUFACTURER
- ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING
Chapter - 5: OVERVIEW OF CONTRACT RESEARCH
- SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
- SELECTING A CONTRACT RESEARCH ORGANIZATION
- RESEARCH PROVIDED BY CONTRACT RESEARCH ORGNIZATIONS
- Table 7 : TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS
Chapter - 6: OVERVIEW OF CONTRACT PACKAGING
- NEEDING A CONTRACT PACKAGER
- SELECTING A CONTRACT PACKAGER
- HIRING A CONTRACT PACKAGER
- TYPES OF PACKAGING
Chapter - 7: PROJECT MANAGEMENT
- SPECIFICATIONS OF PROJECT MANAGEMENT
- PROCESSES OF PROJECT MANAGEMENT
- FACTORS INVOLVED
- ROLE OF THE PROJECT MANAGER
- TECHNOLOGY TRANSFER
- Table 14 : TECHNOLOGY TRANSFER STEPS
Chapter - 8: REGULATORY ASPECTS
- WARNING LETTERS
- REGULATORY APPROVALS
- Table 19 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, JANUARY THROUGH MARCH, 2011
- Table 20 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2010
- Table 21 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2009
Chapter - 9: INDUSTRY STRUCTURE FOR NORTH AMERICA
- MARKET SHARE OF INDUSTRY LEADERS
- CONTRACT MANUFACTURERS OF BULK DRUGS AND API' S
- CONTRACT MANUFACTURERS OF SOLID-DOSAGE FORMS
- CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
- CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
- CONTRACT RESEARCH COMPANIES
- CONTRACT PACKAGING COMPANIES
- Table 28 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH
AMERICA 2010
- Figure 7 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH
AMERICA, 2010
Chapter - 10: INDUSTRY STRUCTURE FOR EUROPE
- MARKET SHARE OF INDUSTRY LEADERS
- CONTRACT MANUFACTURERS OF BULK DRUGS AND API' S
- CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
- CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
- CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS
- CONTRACT RESEARCH COMPANIES
- CONTRACT PACKAGING COMPANIES
- Table 35 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN EUROPE, 2010
- Figure 14 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN EUROPE, 2010
Chapter - 11: INDUSTRY STRUCTURE FOR EMERGING MARKETS
- MARKET SHARE OF INDUSTRY LEADERS
- CONTRACT MANUFACTURERS OF BULK DRUGS AND API' S
- CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
- CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
- CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS
- CONTRACT RESEARCH COMPANIES
- CONTRACT PACKAGING COMPANIES
- TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
- Table 43 : SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
- Table 44 : SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING
TYPE
Chapter - 12: TECHNOLOGY TRANSFER
- REASONS FOR TECHNOLOGY TRANSFER
- CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
- TECHNOLOGY TRANSFER
- TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
- CHARACTERISTICS OF A SUCCESSFUL PROJECT
Chapter - 13: NEW DEVELOPMENTS
- LONZA
- ABBOTT
- HOSPIRA
- COVIDIEN
- OTHER
Chapter - 14: MARKET ANALYSIS FOR NORTH AMERICA
- CONTRACT MANUFACTURING
- CONTRACT RESEARCH
- CONTRACT PACKAGING
Chapter - 15: MARKET ANALYSIS FOR EUROPE
- CONTRACT MANUFACTURING
- CONTRACT RESEARCH
- CONTRACT PACKAGING
Chapter - 16: MARKET ANALYSIS FOR REST OF WORLD/EMERGING MARKETS
- CONTRACT MANUFACTURING
- CONTRACT RESEARCH
- CONTRACT PACKAGING
Chapter - 17: MARKET SHARE BY REGION
- MARKET SHARE OF CONTRACT MANUFACTURED API' S
- MARKET SHARE OF CONTRACT MANUFACTURED SOLID DOSAGE FORMS
- MARKET SHARE OF CONTRACT MANUFACTURED LIQUID DOSAGE FORMULATIONS
- MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID DOSAGE FORMULATIONS
- MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED DRUG DELIVERY PRODUCTS
- MARKET SHARE OF CONTRACT MANUFACTURED OTC AND NUTRITIONAL PRODUCTS
- MARKET SHARE OF CONTRACT RESEARCH
- MARKET SHARE OF CONTRACT PACKAGING
- Table 131 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
- Figure 105 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
Chapter - 18: CONTRACT MANUFACTURING APPLICATIONS FOR NORTH AMERICAN MARKETS
- CARDIOVASCULAR DRUGS
- REPRODUCTIVE DRUG MARKET
- ONCOLOGY DRUG MARKET
- ANALGESICS MARKET
- ANTIVIRAL DRUG MARKET
- ANTIBIOTICS MARKET
- MARKETS FOR OTHER DRUGS
Chapter - 19: CONTRACT MANUFACTURING APPLICATIONS FOR EUROPEAN MARKETS
- CARDIOVASCULAR DRUGS
- REPRODUCTIVE DRUG MARKET
- ONCOLOGY DRUG MARKET
- ANALGESICS MARKET
- ANTIVIRAL DRUG MARKET
- ANTIBIOTICS MARKET
- MARKETS FOR OTHER DRUGS
Chapter - 20: CONTRACT MANUFACTURING APPLICATIONS FOR REST OF THE WORLD (ROW)
- CARDIOVASCULAR DRUGS
- REPRODUCTIVE DRUG MARKET
- ONCOLOGY DRUG MARKET
- ANALGESICS MARKET
- ANTIVIRAL DRUG MARKET
- ANTIBIOTICS MARKET
- MARKETS FOR OTHER DRUGS
Chapter - 21: PATENT ANALYSIS
- PATENTS BY YEAR
- PATENTS BY COMPANY
- PATENTS BY COUNTRY
- PATENTS BY EMPHASIS
- Table 157 : PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
- Figure 132 : NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
Chapter - 22: CURRENT ENVIRONMENT
- SITUATION OF THE NORTH AMERICAN CONTRACTING MARKETS
- SITUATION OF THE EUROPEAN CONTRACTING MARKET
- SITUATION OF THE ROW CONTRACTING MARKET
- OPPORTUNITIES AND CHALLENGES OF THE CURRENT CONTRACT MANUFACTURING INDUSTRY
Chapter - 23: COMPANY PROFILES
- AAI PHARMA, INC.
- ABBOTT LABORATORIES
- AEROGEN LTD.
- ALKERMES
- ALTHEA TECHNOLOGIES
- AMCOR
- AMERISOURCE BERGEN CORPORATION
- AMPAC FINE CHEMICALS
- ALBANY MOLECULAR RESEARCH INC. (AMRI)
- AP PHARMA INC.
- APTUIT INC.
- ARADIGM CORPORATION
- BASF SE
- BAXTER HEALTHCARE
- BCM/BOOTS MANUFACTURING
- BOEHRINGER INGELHEIM
- BRISTOL-MYERS SQUIBB
- CAMBREX CORPORATION
- CANGENE CORPORATION
- CATALENT PHARMA SOLUTIONS
- CEDARBURG HAUSER PHARMACEUTICALS INC.
- CENEXI
- CHARLES RIVER LABORATORIES
- CHEMBRIDGE CORP.
- CLEARSTONE CENTRAL LABORATORIES
- CONFAB LABORATORIES
- COVANCE INC.
- COVIDIEN
- CONTRACT PHARMACEUTICALS LIMITED
- CORDEN PHARMA SWITZERLAND LLC
- DAVOS PHARMA
- DECODE GENETICS
- DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
- DOW CHEMICAL
- DPT LABORATORIES INC.
- DR. REDDY' S LABORATORIES
- DSM PHARMACEUTICAL PRODUCTS
- FUJIFILM DIOSYNTH BIOTECHNOLOGY
- ELAN DRUG TECHNOLOGIES
- EVOTEC AG
- FULCRUM PHARMA PLC
- GIRINDUS AG
- GLAXOSMITHKLINE
- HOSPIRA
- HAUPT PHARMA AG
- HOVIONE S.A.
- ICON PLC
- INC RESEARCH, INC.
- JUBILANT LIFESCIENCES
- KENDLE INTERNATIONAL INC.
- KP PHARMACEUTICAL TECHNOLOGIES INC.
- K.V. PHARMACEUTICAL CO.
- LIGAND PHARMACEUTICALS, INC.
- LONZA GROUP
- LYNE LABORATORIES
- MERCK / MSD BIOMANUFACTURING NETWORK
- MIKART INC
- NEXTPHARMA TECHNOLOGIES
- NORWICH PHARMACEUTICALS
- NOVAVAX, INC.
- OMNICARE CLINICAL RESEARCH
- PAREXEL INTERNATIONAL CORPORATION
- PATHEON INC.
- PERRIGO COMPANY
- PFIZER (KING PHARMACEUTICALS)
- PIRAMAL HEALTHCARE LIMITED
- PPD
- PRA INTERNATIONAL
- QUINTILES
- RANBAXY
- REGIS TECHNOLOGIES, INC.
- SKYEPHARMA
- TALECRIS BIOTHERAPEUTICS INC.
- VETTER PHARMA INTERNATIONAL GMBH
- WOCKHARDT LIMITED
- WUXI APP TEC
- XCELLEREX LLC
- ZACH SYSTEM S.P.A
Chapter - 24: APPENDIX I: ABBREVIATIONS
List of Tables
- Summary Table : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT
RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016
- Table 1 : KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
- Table 2 : KEY ADVANTAGES OF CONTRACT MANUFACTURING
- Table 3 : KEY DISADVANTAGES OF CONTRACT MANUFACTURING
- Table 4 : KEY FACTORS IN SELECTING A CONTRACT MANUFACTURER
- Table 5 : SERVICES OF CONTRACT RESEARCH ORGANIZATIONS
- Table 6 : KEY CHARACTERISITCS IN SELECTING A CONTRACT RESEARCH ORGANIZATION
- Table 7 : TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS
- Table 8 : REASONS BEHIND NEEDING A CONTRACT PACKAGER
- Table 9 : KEY CHARACTERISTICS IN SELECTING A CONTRACT PACKAGER
- Table 10 : KEY STEPS IN HIRING A CONTRACT PACKAGER
- Table 11 : STEPS OF PROJECT MANAGEMENT
- Table 12 : PROCESSES OF PROJECT MANAGEMENT
- Table 13 : KEY RESPONSIBILITIES OF PROJECT MANAGERS
- Table 14 : TECHNOLOGY TRANSFER STEPS
- Table 15 : REGULATED FACTORS OF CMO' S AND CRO' S
- Table 16 : TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT MANUFACTURING
- Table 17 : WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2010
- Table 18 : WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2009
- Table 19 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES,
JANUARY THROUGH MARCH, 2011
- Table 20 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES,
2010
- Table 21 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES,
2009
- Table 22 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK
DRUGS/API' S, IN NORTH AMERICA, 2010
- Table 23 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Table 24 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Table 25 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Table 26 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Table 27 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH AMERICA,
2010
- Table 28 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA
2010
- Table 29 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK
DRUGS/API' S, IN EUROPE, 2010
- Table 30 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SOLID DOSAGE FORMS, IN EUROPE, 2010
- Table 31 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010
- Table 32 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010
- Table 33 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SEMISOLID DOSAGE FORMS, IN EUROPE, 2010
- Table 34 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN EUROPE, 2010
- Table 35 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN EUROPE, 2010
- Table 36 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK
DRUGS/API' S, IN REST OF WORLD, 2010
- Table 37 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SOLID DOSAGE FORMS, 2010
- Table 38 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
NONSTERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010
- Table 39 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
STERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010
- Table 40 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SEMISOLID DOSAGE FORMS, IN REST OF WORLD, 2010
- Table 41 : MARKET SHARES OF CONTRACT RESEARCH COMPANIES, IN REST OF WORLD,
2010
- Table 42 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN REST OF WORLD,
2010
- Table 43 : SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
- Table 44 : SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE
- Table 45 : BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA,
THROUGH 2016
- Table 46 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA,
THROUGH 2016
- Table 47 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR NORTH AMERICA, THROUGH 2016
- Table 48 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY
FORMULATION, FOR NORTH AMERICA, 2010
- Table 49 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR
NORTH AMERICA, THROUGH 2016
- Table 50 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR NORTH
AMERICA, THROUGH 2016
- Table 51 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE,
BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
- Table 52 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARES BY FORMULATION, FOR NORTH AMERICA, 2010
- Table 53 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR NORTH AMERICA, THROUGH 2016
- Table 54 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
- Table 55 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH
AMERICA, THROUGH 2016
- Table 56 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR NORTH AMERICA, THROUGH 2016
- Table 57 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
FORMULATION, FOR NORTH AMERICA, 2010
- Table 58 : CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS
- Table 59 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
- Table 60 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, THROUGH 2016
- Table 61 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, 2010
- Table 62 : OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY
CONTRACT MANUFACTURING, THROUGH 2016
- Table 63 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING REVENUE
BY FORMULATION FOR NORTH AMERICA, THROUGH 2016
- Table 64 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
- Table 65 : CONTRACT RESEARCH REVENUE FOR NORTH AMERICA, THROUGH 2016
- Table 66 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA,
THROUGH 2016
- Table 67 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH
AMERICA, 2010
- Table 68 : CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, THROUGH 2016
- Table 69 : CONTRACT PACKAGING REVENUE BY TYPE, FOR NORTH AMERICA, THROUGH
2016
- Table 70 : CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH AMERICA,
2010
- Table 71 : BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOR EUROPE,
THROUGH 2016
- Table 72 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE, THROUGH
2016
- Table 73 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR EUROPE, THROUGH 2016
- Table 74 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY
FORMULATION, FOR EUROPE, 2010
- Table 75 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR
EUROPE, THROUGH 2016
- Table 76 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
EUROPE, THROUGH 2016
- Table 77 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE,
BY FORMULATION, FOR EUROPE, THROUGH 2016
- Table 78 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARES, BY FORMULATION, FOR EUROPE, 2010
- Table 79 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR EUROPE, THROUGH 2016
- Table 80 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR EUROPE, 2010
- Table 81 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE,
THROUGH 2016
- Table 82 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR EUROPE, THROUGH 2016
- Table 83 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
FORMULATION, FOR EUROPE, 2010
- Table 84 : CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
- Table 85 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016
- Table 86 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016
- Table 87 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR EUROPE, 2010
- Table 88 : OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016
- Table 89 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING REVENUE,
BY FORMULATION, FOR EUROPE, THROUGH 2016
- Table 90 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR EUROPE, 2010
- Table 91 : CONTRACT RESEARCH REVENUE, FOR EUROPE, THROUGH 2016
- Table 92 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE, THROUGH
2016
- Table 93 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR EUROPE, 2010
- Table 94 : CONTRACT PACKAGING REVENUE, FOR EUROPE, THROUGH 2016
- Table 95 : CONTRACT PACKAGING REVENUE BY TYPE, FOR EUROPE, THROUGH 2016
- Table 96 : CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE, 2010
- Table 97 : REST OF WORLD BULK DRUG/API' S CONTRACT MANUFACTURING REVENUE,
THROUGH 2016
- Table 98 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF WORLD,
THROUGH 2016
- Table 99 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR REST OF WORLD, THROUGH 2016
- Table 100 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
FORMULATION, FOR REST OF WORLD, 2010
- Table 101 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING FOR
REST OF WORLD, THROUGH 2016
- Table 102 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR REST
OF WORLD, THROUGH 2016
- Table 103 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, THROUGH 2016
- Table 104 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR REST OF WORLD, 2010
- Table 105 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY
FORMULATION FOR REST OF WORLD, THROUGH 2016
- Table 106 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR REST OF WORLD, 2010
- Table 107 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF
WORLD, THROUGH 2016
- Table 108 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY
FORMULATION, FOR REST OF WORLD, THROUGH 2016
- Table 109 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE BY
FORMULATION, FOR REST OF WORLD, 2010
- Table 110 : CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS IN ROW
- Table 111 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016
- Table 112 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, THROUGH 2016
- Table 113 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010
- Table 114 : OTC AND NUTRITIONAL PRODUCTS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016
- Table 115 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, THROUGH 2016
- Table 116 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR REST OF WORLD, 2010
- Table 117 : CONTRACT RESEARCH REVENUE FOR REST OF WORLD, THROUGH 2016
- Table 118 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR REST OF WORLD,
THROUGH 2016
- Table 119 : CONTRACT RESEARCH MARKET SHARE BY DISCIPLINE, FOR REST OF
WORLD, 2010
- Table 120 : CONTRACT PACKAGING REVENUE, FOR REST OF WORLD, THROUGH 2016
- Table 121 : CONTRACT PACKAGING REVENUE BY TYPE, FOR REST OF WORLD, THROUGH
2016
- Table 122 : CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR REST OF WORLD,
2010
- Table 123 : BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY REGION,
2010
- Table 124 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010
- Table 125 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010
- Table 126 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010
- Table 127 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY
REGION, 2010
- Table 128 : DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY REGION,
2010
- Table 129 : OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010
- Table 130 : CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010
- Table 131 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
- Table 132 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS,
IN NORTH AMERICA, THROUGH 2016
- Table 133 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN
NORTH AMERICA, THROUGH 2016
- Table 134 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN
NORTH AMERICA, THROUGH 2016
- Table 135 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN NORTH
AMERICA, THROUGH 2016
- Table 136 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN NORTH
AMERICA, THROUGH 2016
- Table 137 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN NORTH
AMERICA, THROUGH 2016
- Table 138 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN NORTH
AMERICA, THROUGH 2016
- Table 139 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS,
IN EUROPE, THROUGH 2016
- Table 140 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN
EUROPE, THROUGH 2016
- Table 141 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN
EUROPE, THROUGH 2016
- Table 142 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN EUROPE,
THROUGH 2016
- Table 143 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN EUROPE,
THROUGH 2016
- Table 144 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN EUROPE,
THROUGH 2016
- Table 145 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN EUROPE,
THROUGH 2016
- Table 146 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS,
IN REST OF WORLD, THROUGH 2016
- Table 147 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN
REST OF WORLD, THROUGH 2016
- Table 148 : REVENUE FROM CONTRACT MANUFACTURERS OF DRUGS USED IN ONCOLOGY,
IN REST OF WORLD, THROUGH 2016
- Table 149 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN REST OF
WORLD, THROUGH 2016
- Table 150 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN REST OF
WORLD, THROUGH 2016
- Table 151 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN REST OF
WORLD, THROUGH 2016
- Table 152 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN REST OF
WORLD, THROUGH 2016
- Table 153 : NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-2011
- Table 154 : NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
- Table 155 : NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
- Table 156 : PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011
- Table 157 : PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
List of Figures
- Summary Figure : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT
RESEARCH ORGANIZATIONS REVENUE, 2009-2016
- Figure 1 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK
DRUGS/API' S, IN NORTH AMERICA, 2010
- Figure 2 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Figure 3 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Figure 4 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Figure 5 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
- Figure 6 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH AMERICA,
2010
- Figure 7 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA,
2010
- Figure 8 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK
DRUGS/API' S, IN EUROPE, 2010
- Figure 9 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SOLID DOSAGE FORMS, IN EUROPE, 2010
- Figure 10 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010
- Figure 11 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010
- Figure 12 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SEMISOLID DOSAGE FORMS, IN EUROPE, 2010
- Figure 13 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN EUROPE, 2010
- Figure 14 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN EUROPE, 2010
- Figure 15 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
BULK DRUGS/API' S, IN REST OF WORLD, 2010
- Figure 16 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SOLID DOSAGE FORMS, IN REST OF WORLD, 2010
- Figure 17 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
NONSTERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010
- Figure 18 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
STERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010
- Figure 19 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING
SEMISOLID DOSAGE FORMS, IN REST OF WORLD, 2010
- Figure 20 : MARKET SHARES OF CONTRACT RESEARCH COMPANIES, IN REST OF
WORLD, 2010
- Figure 21 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN REST OF
WORLD, 2010
- Figure 22 : BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA,
2009-2016
- Figure 23 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA,
2009-2016
- Figure 24 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATIONS, FOR NORTH AMERICA, 2009-2016
- Figure 25 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY
FORMULATIONS, FOR NORTH AMERICA, 2010
- Figure 26 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR
NORTH AMERICA, 2009-2016
- Figure 27 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR NORTH
AMERICA, THROUGH 2016
- Figure 28 : LIQUID DOSAGE FORM (NON STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
- Figure 29 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARES, BY FORMULATION, FOR NORTH AMERICA, 2010
- Figure 30 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE,
BY FORMULATION, FOR NORTH AMERICA, 2009-2016
- Figure 31 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
- Figure 32 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH
AMERICA, 2009-2016
- Figure 33 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR NORTH AMERICA, 2009-2016
- Figure 34 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
FORMULATION, FOR NORTH AMERICA, 2010
- Figure 35 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
- Figure 36 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATIONS, 2009-2016
- Figure 37 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATIONS, 2010
- Figure 38 : OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY
CONTRACT MANUFACTURING, 2009-2016
- Figure 39 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
- Figure 40 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATIONS, FOR NORTH AMERICA, 2010
- Figure 41 : CONTRACT RESEARCH REVENUE, FOR NORTH AMERICA, 2009-2016
- Figure 42 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA,
2009-2016
- Figure 43 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH
AMERICA, 2010
- Figure 44 : CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, 2009-2016
- Figure 45 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA,
2009-2016
- Figure 46 : CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH AMERICA,
2010
- Figure 47 : BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOR EUROPE,
2009-2016
- Figure 48 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE, 2009-
2016
- Figure 49 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATIONS, FOR EUROPE, 2009-2016
- Figure 50 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY
FORMULATIONS, FOR EUROPE, 2010
- Figure 51 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR
EUROPE, 2009-2016
- Figure 52 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
EUROPE, 2009-2016
- Figure 53 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016
- Figure 54 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARES, BY FORMULATIONS, FOR EUROPE, 2010
- Figure 55 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE,
BY FORMULATION, FOR EUROPE, 2009-2016
- Figure 56 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATIONS, FOR EUROPE, 2010
- Figure 57 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE,
2009-2016
- Figure 58 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATIONS, FOR EUROPE, 2009-2016
- Figure 59 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
FORMULATIONS, FOR EUROPE, 2010
- Figure 60 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016
- Figure 61 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016
- Figure 62 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010
- Figure 63 : OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016
- Figure 64 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016
- Figure 65 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATIONS, FOR EUROPE, 2010
- Figure 66 : CONTRACT RESEARCH REVENUE, FOR EUROPE, 2009-2016
- Figure 67 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE, 2009-2016
- Figure 68 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR EUROPE, 2010
- Figure 69 : CONTRACT PACKAGING REVENUE, FOR EUROPE, 2009-2016
- Figure 70 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE, 2009-2016
- Figure 71 : CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE, 2010
- Figure 72 : REST OF WORLD BULK DRUG/API' S CONTRACT MANUFACTURING REVENUE,
2009-2016
- Figure 73 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF WORLD,
2009-2016
- Figure 74 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR REST OF WORLD, 2009-2016
- Figure 75 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE BY
FORMULATION, FOR REST OF WORLD, 2010
- Figure 76 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING FOR
REST OF WORLD, 2009-2016
- Figure 77 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR REST
OF WORLD, 2009-2016
- Figure 78 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, 2009-2016
- Figure 79 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR REST OF WORLD, 2010
- Figure 80 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY
FORMULATION, FOR REST OF WORLD, 2009-2016
- Figure 81 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR REST OF WORLD, 2010
- Figure 82 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF
WORLD, 2009-2016
- Figure 83 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY
FORMULATION, FOR REST OF WORLD, 2009-2016
- Figure 84 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE BY
FORMULATION, FOR REST OF WORLD, 2010
- Figure 85 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016
- Figure 86 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, 2009-2016
- Figure 87 : ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010
- Figure 88 : OTC AND NUTRITIONAL PRODUCTS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, 2009-2016
- Figure 89 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR REST OF WORLD, 2009-2016
- Figure 90 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR REST OF WORLD, 2009-2016
- Figure 91 : CONTRACT RESEARCH REVENUE FOR REST OF WORLD, 2009-2016
- Figure 92 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR REST OF WORLD,
2009-2016
- Figure 93 : CONTRACT RESEARCH MARKET SHARE BY DISCIPLINE, FOR REST OF
WORLD, 2010
- Figure 94 : CONTRACT PACKAGING REVENUE, FOR REST OF WORLD, 2009-2016
- Figure 95 : CONTRACT RESEARCH REVENUE BY DISCIPLINE FOR REST OF WORLD,
THROUGH 2016
- Figure 96 : CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR REST OF WORLD,
2010
- Figure 97 : BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY REGION,
2010
- Figure 98 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010
- Figure 99 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010
- Figure 100 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010
- Figure 101 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010
- Figure 102 : DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY REGION,
2010
- Figure 103 : OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010
- Figure 104 : CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010
- Figure 105 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
- Figure 106 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS,
IN NORTH AMERICA, 2009-2016
- Figure 107 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN
NORTH AMERICA, 2009-2016
- Figure 108 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN
NORTH AMERICA, 2009-2016
- Figure 109 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN NORTH
AMERICA, 2009-2016
- Figure 110 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN NORTH
AMERICA, 2009-2016
- Figure 111 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN NORTH
AMERICA, 2009-2016
- Figure 112 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN NORTH
AMERICA, 2009-2016
- Figure 113 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS,
IN EUROPE, 2009-2016
- Figure 114 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN
EUROPE, 2009-2016
- Figure 115 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN
EUROPE, 2009-2016
- Figure 116 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN EUROPE,
2009-2016
- Figure 117 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN EUROPE,
2009-2016
- Figure 118 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN
EUROPE, 2009-2016
- Figure 119 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN
EUROPE, 2009-2016
- Figure 120 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS,
IN REST OF WORLD, 2009-2016
- Figure 121 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN
REST OF WORLD, 2009-2016
- Figure 122 : REVENUE FROM CONTRACT MANUFACTURERS OF DRUGS USED IN
ONCOLOGY, IN REST OF WORLD, 2009-2016
- Figure 123 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN REST OF
WORLD, 2009-2016
- Figure 124 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN REST OF
WORLD, 2009-2016
- Figure 125 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN REST
OF WORLD, 2009-2016
- Figure 126 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN REST
OF WORLD, 2009-2016
- Figure 127 : NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
- Figure 128 : NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
- Figure 129 : NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
- Figure 130 : NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
- Figure 131 : PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011
- Figure 132 : NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
|
 |
